InterOcean Capital Group LLC Buys 128 Shares of HCA Healthcare, Inc. (NYSE:HCA)

InterOcean Capital Group LLC lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 4.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,339 shares of the company’s stock after purchasing an additional 128 shares during the quarter. InterOcean Capital Group LLC’s holdings in HCA Healthcare were worth $904,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in HCA. Stone House Investment Management LLC acquired a new position in HCA Healthcare during the third quarter worth $25,000. Centerpoint Advisors LLC acquired a new position in shares of HCA Healthcare in the fourth quarter valued at $27,000. Atlantic Edge Private Wealth Management LLC bought a new stake in shares of HCA Healthcare in the fourth quarter valued at about $27,000. Bruce G. Allen Investments LLC bought a new stake in HCA Healthcare during the fourth quarter worth about $28,000. Finally, Annis Gardner Whiting Capital Advisors LLC bought a new stake in HCA Healthcare during the third quarter worth about $30,000. Institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 6,311 shares of the firm’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $316.88, for a total value of $1,999,829.68. Following the transaction, the executive vice president now owns 29,624 shares of the company’s stock, valued at $9,387,253.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Michael S. Cuffe sold 6,311 shares of HCA Healthcare stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $316.88, for a total transaction of $1,999,829.68. Following the sale, the executive vice president now owns 29,624 shares of the company’s stock, valued at approximately $9,387,253.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Chad J. Wasserman sold 344 shares of HCA Healthcare stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $321.97, for a total value of $110,757.68. Following the completion of the sale, the senior vice president now directly owns 2,452 shares in the company, valued at approximately $789,470.44. The disclosure for this sale can be found here. Insiders have sold 13,617 shares of company stock valued at $4,321,986 over the last ninety days. Insiders own 1.70% of the company’s stock.

HCA Healthcare Price Performance

HCA traded down $3.22 during midday trading on Thursday, hitting $315.19. The stock had a trading volume of 82,214 shares, compared to its average volume of 1,065,350. The company has a market cap of $82.55 billion, a P/E ratio of 15.88, a price-to-earnings-growth ratio of 1.49 and a beta of 1.66. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $335.83. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16. The business has a fifty day moving average of $319.38 and a 200 day moving average of $304.51.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The business had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $16.81 billion. During the same quarter in the prior year, the company earned $4.93 earnings per share. The firm’s quarterly revenue was up 11.2% compared to the same quarter last year. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 20.84 earnings per share for the current fiscal year.

HCA Healthcare announced that its board has authorized a stock buyback plan on Tuesday, January 30th that permits the company to buyback $6.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 7.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board believes its shares are undervalued.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 annualized dividend and a dividend yield of 0.84%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Analyst Ratings Changes

A number of research firms have recently commented on HCA. Truist Financial increased their target price on shares of HCA Healthcare from $320.00 to $345.00 and gave the stock a “buy” rating in a report on Wednesday, January 31st. Barclays increased their target price on HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a report on Monday, April 29th. Royal Bank of Canada increased their target price on HCA Healthcare from $322.00 to $329.00 and gave the stock an “outperform” rating in a report on Monday, April 29th. Oppenheimer increased their target price on HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a report on Monday, April 29th. Finally, StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, May 18th. Four equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $317.00.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.